Mink Therapeutics Inc (INKT)

Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	56.73%1.89	1.20	1.51	-	-
Research and Development	56.73%1.89	1.20	1.51	-	-
Other Operating Expenses	5.88%0.56	0.60	0.10	-	-
Interest Income/Expense	50.00%-0.00	-0.00	-0.03	-0.03	-0.03
Operating Income/Loss	11.63%-3.22	-2.88	-2.71	-3.18	-4.05
Net Interest Income/Expense	9.83%0.07	0.08	0.11	0.06	0.00
	14.07%-3.13	-2.74	-2.60	-2.89	-4.24
Attributable To Parent	14.07%-3.13	-2.74	-2.60	-2.89	-4.24
Basic Average Shares	4.70%5.02	4.80	-	4.44	3.98
Diluted Average Shares	4.70%5.02	4.80	-	4.44	3.98
Basic Earnings Per Share	8.77%-0.62	-0.57	-	-0.65	-1.06
Diluted Earnings Per Share	8.77%-0.62	-0.57	-	-0.65	-1.06